1. Home
  2. HCWB vs AUUD Comparison

HCWB vs AUUD Comparison

Compare HCWB & AUUD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HCW Biologics Inc.

HCWB

HCW Biologics Inc.

HOLD

Current Price

$1.36

Market Cap

3.8M

Sector

Health Care

ML Signal

HOLD

Logo Auddia Inc.

AUUD

Auddia Inc.

HOLD

Current Price

$0.89

Market Cap

3.1M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
HCWB
AUUD
Founded
2018
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
3.8M
3.1M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
HCWB
AUUD
Price
$1.36
$0.89
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$35.00
N/A
AVG Volume (30 Days)
56.3K
94.9K
Earning Date
11-14-2025
03-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$422,026.00
N/A
Revenue This Year
$178.64
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.95
$0.84
52 Week High
$41.20
$14.60

Technical Indicators

Market Signals
Indicator
HCWB
AUUD
Relative Strength Index (RSI) 44.27 42.49
Support Level $1.10 $0.92
Resistance Level $1.35 $1.04
Average True Range (ATR) 0.13 0.07
MACD 0.06 0.00
Stochastic Oscillator 89.07 51.01

Price Performance

Historical Comparison
HCWB
AUUD

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.

About AUUD Auddia Inc.

Auddia Inc is a technology company that is engaged in radio broadcasts and streaming audio content digitally. Its products includes Auddia App which is a subscription-based commercial-free AM/FM software application, and Vodacast an interactive podcasting platform and application. The company generates revenue through subscription fees from customers accessing the company's cloud-based computing services and advertisement services.

Share on Social Networks: